|
|
||||||||
1 From the Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison; the 2 Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota; and the 3 Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
PURPOSE. To determine the effects of latrunculin (LAT)-A or -B on intraocular pressure (IOP), aqueous humor flow (AHF), anterior chamber (AC) protein concentration ([protein]AC), corneal endothelial permeability and morphology, and corneal thickness in living cynomolgus monkeys.
METHODS. Topical LAT-A or LAT-B was administered to one eye, and vehicle to the other. IOP was measured by Goldmann tonometry, AHF and corneal endothelium transfer coefficient (ka) by fluorophotometry, [protein]AC by Lowry assay, corneal endothelial cell morphology by specular microphotography, and corneal thickness by ultrasound pachymetry.
RESULTS. LAT-A began to lower IOP at 6 hours and maximally reduced IOP by 4.6 mm Hg at 9 hours. LAT-B lowered IOP within 1 hour and maximally reduced IOP by 3.1 mm Hg at 6 hours. LAT-A increased AHF by 87% for 3 hours and increased ka by 94% over 6 hours; LAT-B increased ka by 39% over 6 hours without affecting AHF. LAT-A increased IV fluorescein entry into the cornea approximately 10 fold, but did not affect IV fluorescein entry into the AC. LAT-A increased [protein]AC by 25% at 2 hours but not 5.5 hours. LAT-B variably and insignificantly increased [protein]AC at 1 hour but not at 6.5 hours. LAT-A induced extensive corneal endothelial pseudoguttata within 1 hour, with normal cell counts by 7 days. LAT-B increased central corneal thickness maximally by 47 µm at 3.5 hours.
CONCLUSIONS. LAT-A and -B significantly reduced IOP and were consistent in their facility-increasing effect, indicating that pharmacologic disorganization of the actin cytoskeleton in the trabecular meshwork by latrunculins may be a useful antiglaucoma strategy. However, effects on corneal endothelium or ciliary epithelium are a potential safety issue.
This article has been cited by other articles:
![]() |
C. R. Ethier, A. T. Read, and D. W.-H. Chan Effects of Latrunculin-B on Outflow Facility and Trabecular Meshwork Structure in Human Eyes Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1991 - 1998. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okka, B. Tian, and P. L. Kaufman Effect of Latrunculin B on Intraocular Pressure in the Monkey Eye--Reply Arch Ophthalmol, October 1, 2005; 123(10): 1457 - 1457. [Full Text] [PDF] |
||||
![]() |
H. Fan, S. K. Rao, Y. S. Zhou, and D. S. C. Lam Effect of Latrunculin B on Intraocular Pressure in the Monkey Eye Arch Ophthalmol, October 1, 2005; 123(10): 1456 - 1457. [Full Text] [PDF] |
||||
![]() |
J. Song, P.-F. Deng, S. S. Stinnett, D. L. Epstein, and P. V. Rao Effects of Cholesterol-Lowering Statins on the Aqueous Humor Outflow Pathway Invest. Ophthalmol. Vis. Sci., July 1, 2005; 46(7): 2424 - 2432. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Peterson, N. Sheibani, G. David, A. Garcia-Pardo, and D. M. Peters Heparin II Domain of Fibronectin Uses {alpha}4{beta}1 Integrin to Control Focal Adhesion and Stress Fiber Formation, Independent of Syndecan-4 J. Biol. Chem., February 25, 2005; 280(8): 6915 - 6922. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okka, B. Tian, and P. L. Kaufman Effect of Low-Dose Latrunculin B on Anterior Segment Physiologic Features in the Monkey Eye Arch Ophthalmol, October 1, 2004; 122(10): 1482 - 1488. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Santas, C. Bahler, J. A. Peterson, M. S. Filla, P. L. Kaufman, E. R. Tamm, D. H. Johnson, and D. M. P. Peters Effect of Heparin II Domain of Fibronectin on Aqueous Outflow in Cultured Anterior Segments of Human Eyes Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4796 - 4804. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Tian, J. A. Kiland, and P. L. Kaufman Effects of the Marine Macrolides Swinholide A and Jasplakinolide on Outflow Facility in Monkeys Invest. Ophthalmol. Vis. Sci., December 1, 2001; 42(13): 3187 - 3192. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. V. Rao, P.-F. Deng, J. Kumar, and D. L. Epstein Modulation of Aqueous Humor Outflow Facility by the Rho Kinase-Specific Inhibitor Y-27632 Invest. Ophthalmol. Vis. Sci., April 1, 2001; 42(5): 1029 - 1037. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |